Almotriptan information

Almotriptan
Clinical data
Trade names	Axert
AHFS/Drugs.com	Monograph
MedlinePlus	a603028
License data	US DailyMed: Almotriptan;
Routes of; administration	By mouth
ATC code	N02CC05 (WHO) ;
Legal status
Legal status	UK: POM (Prescription only); US: ℞-only; EU: Rx-only; In general: ℞ (Prescription only);
Pharmacokinetic data
Bioavailability	70%
Protein binding	35%
Metabolism	Liver
Elimination half-life	3–4 hours
Identifiers
	IUPAC name N,N-dimethyl-2- [5-(pyrrolidin-1-ylsulfonylmethyl)- 1H-indol-3-yl]-ethanamine;
CAS Number	154323-57-6 ;
PubChem CID	123606;
IUPHAR/BPS	7110;
DrugBank	DB00918 ;
ChemSpider	110198 ;
UNII	1O4XL5SN61;
KEGG	D02824 ; as salt: D02825 ;
ChEBI	CHEBI:520985 ;
ChEMBL	ChEMBL1505 ;
CompTox Dashboard (EPA)	DTXSID5044289 ;
Chemical and physical data
Formula	C17H25N3O2S
Molar mass	335.47 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CN(C)CCc2c[nH]c3ccc(CS(=O)(=O)N1CCCC1)cc23;
	InChI InChI=1S/C17H25N3O2S/c1-19(2)10-7-15-12-18-17-6-5-14(11-16(15)17)13-23(21,22)20-8-3-4-9-20/h5-6,11-12,18H,3-4,7-10,13H2,1-2H3 ; Key:WKEMJKQOLOHJLZ-UHFFFAOYSA-N ;
	(what is this?) (verify)

Almotriptan (trade name Axert and others) is a triptan medication discovered and developed by Almirall for the treatment of heavy migraine headache.

It was patented in 1992 and approved for medical use in 2000.^[4]

^ "Almotriptan tablet, film coated". DailyMed. Retrieved 17 February 2021.
^ "Axert- almotriptan malate tablet, coated". DailyMed. Retrieved 17 February 2021.
^ "Active substance: almotriptan" (PDF). List of nationally authorised medicinal products. Europeans Medicines Agency. 11 February 2021.
^ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 531. ISBN 9783527607495.

[1] "Almotriptan tablet, film coated". DailyMed. Retrieved 17 February 2021.

[Axert_FDA_label-2] "Axert- almotriptan malate tablet, coated". DailyMed. Retrieved 17 February 2021.

[3] "Active substance: almotriptan" (PDF). List of nationally authorised medicinal products. Europeans Medicines Agency. 11 February 2021.

[Fis2006-4] Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 531. ISBN 9783527607495.

Almotriptan information

and 27 Related for: Almotriptan information

Almotriptan

MDMA

LSD

Nitrous oxide

Cannabidiol

Quetiapine

Xenon

Aripiprazole

Serotonin receptor agonist

Bupropion

Vortioxetine

Promethazine

Trazodone

Diphenhydramine

Fluoxetine

Tramadol

Monoamine oxidase inhibitor

Olanzapine

Ondansetron

Prochlorperazine

Cyclobenzaprine

Chlorpromazine

Clozapine

Metoclopramide

Almirall

Tryptophan

Psilocybin